A-119

阿立哌唑 溶液

1.0 mg/mL (50:50 Methanol/Water with 1% 1N HCl), ampule of 1 mL, certified reference material, Cerilliant^®

• 经验公式（希尔记法）: C₂₃H₂₇Cl₂N₃O₂
• CAS号: 129722-12-9
• 分子量: 448.39
• MDL號碼: MFCD00892072
• 分類程式碼代碼: 41116107
• PubChem物質ID: 329770682
• NACRES: NA.24

属性

• 等級: certified reference material
• 品質等級: 300
• 形狀: liquid
• 特點: (Snap-N-Spike^®)
• 包裝: ampule of 1 mL
• 製造商／商標名: Cerilliant^®
• 濃度: 1.0 mg/mL (50:50 Methanol/Water with 1% 1N HCl)
• 技術: gas chromatography (GC): suitable; liquid chromatography (LC): suitable
• 應用: clinical testing
• 格式: single component solution
• 儲存溫度: −20°C
• SMILES 字串: O=C(N1)CCC(C1=C2)=CC=C2OCCCCN(CC3)CCN3C4=CC=CC(Cl)=C4Cl
• InChI: 1S/C23H27Cl2N3O2/c24-19-4-3-5-21(23(19)25)28-13-11-27(12-14-28)10-1-2-15-30-18-8-6-17-7-9-22(29)26-20(17)16-18/h3-6,8,16H,1-2,7,9-15H2,(H,26,29)
• InChI 密鑰: CEUORZQYGODEFX-UHFFFAOYSA-N
• 基因資訊: human ... DRD2(1813) , HTR1A(3350) , HTR2A(3356)

说明

一般說明

用于LC或GC应用（包括法医药物分析或校准品制备）的认证溶液标准品。阿立哌唑作为非典型抗精神病药Abilify^®销售，用于精神分裂症，双相障碍和临床抑郁的治疗。

應用

• Psychoactive Drug Detection: The development of a fast UPLC-MS/MS method for detecting psychoactive drugs and metabolites in blood, which utilized Interference Mix 6, underscores its critical application in forensic toxicology and clinical pharmacology, aiding in post-mortem analysis (Barone et al., 2023).

法律資訊

Abilify is a registered trademark of Otsuka Pharmaceutical Co.

CERILLIANT is a registered trademark of Merck KGaA, Darmstadt, Germany

Snap-N-Spike is a registered trademark of Merck KGaA, Darmstadt, Germany

安全信息

• 象形圖: GHS02,GHS06,GHS08
• 訊號詞: Danger
• 危險聲明: H225,H301 + H311 + H331,H370
• 防範說明: P210 - P233 - P280 - P301 + P310 - P303 + P361 + P353 - P304 + P340 + P311
• 危險分類: Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Flam. Liq. 2 - STOT SE 1
• 標靶器官: Eyes,Central nervous system
• 儲存類別代碼: 3 - Flammable liquids
• 水污染物質分類（WGK）: WGK 2
• 閃點（°F）: 51.8 °F
• 閃點（°C）: 11 °C